Global Rapid Influenza Diagnostic Tests Market Is Driven By Increasing Prevalence Of Influenza

By Author: Ben
Total Articles: 165
Comment this article

The global rapid influenza diagnostic tests market comprises diagnostic tests and kits that can detect influenza viruses within 15-30 minutes. Rapid influenza diagnostic tests provide quick point-of-care diagnosis of influenza by identifying influenza viral nucleic acids or antigens in respiratory specimens. These tests help in timely influenza diagnosis and facilitate faster clinical management decisions. They provide an alternative to more laborious viral culture tests or polymerase chain reaction tests which take several hours to yield results. The rising prevalence of influenza infections due to changing demographics, virus mutations, and other factors is driving the demand for rapid diagnosis tests for timely treatment and infection control.

The Global rapid influenza diagnostic tests market is estimated to be valued at US$ 1.29 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the global rapid influenza diagnostic tests market are Quidel Corporation, Becton Dickinson, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffmann-La ...
... Roche, DiaSorin, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, Sekisui Diagnostics, and Virax Biolabs. Quidel Corporation and Becton Dickinson currently dominate the market.

The growing prevalence of influenza and increasing awareness regarding rapid diagnosis is fueling the demand for rapid Influenza Diagnostic Tests globally. Rapid point-of-care testing allows timely clinical management and treatment of influenza cases.

Major manufacturers are expanding their presence in developing markets like Asia Pacific, Middle East, and Africa. Rapid technological advancements are also helping to develop more accurate, affordable, and easy-to-use rapid influenza diagnostic tests.

Market Drivers

The increasing prevalence of influenza outbreaks due to mutations in influenza viruses is a major driver for this market. Rapid diagnosis allows timely treatment and check on spread of infection. As per WHO, there are 1 billion cases of influenza reported annually worldwide with 3-5 million severe illnesses. Rapid diagnosis ensures quicker treatment and care, especially for high-risk groups. Point-of-care testing facilitated by RIDs allows testing and surveillance in primary care facilities and remote locations devoid of advanced laboratory infrastructure. This further aids in clinical management and check on spread of infection.

Impact Of Geopolitical Situation On The Growth Of Global Rapid Influenza Diagnostic Tests Market

The current geopolitical tensions and conflicts across various regions are negatively impacting the growth of the global rapid influenza diagnostic tests market. The ongoing Russia-Ukraine war has disrupted the supply chain and logistics network in Eastern Europe. This is hampering the easy availability of rapid influenza diagnostic kits and related medical devices in the region. Similarly, the rising political instability and internal conflicts in several African and Middle Eastern countries are affecting the market expansion. The healthcare infrastructures have suffered setbacks. Many people do not have access to rapid testing facilities.

To regain the lost growth momentum, manufacturers must seek alternative sourcing and distribution channels. They need to establish new trade partnerships to ensure uninterrupted supplies. Additionally, companies should diversify their production bases beyond the geopolitically volatile areas. Investing in digital technologies can help make diagnostic solutions more accessible in remote and conflict-ridden regions as well. Telehealth and home testing kits can overcome infrastructure barriers. Collaborating with local medical groups and NGOs can facilitate better service delivery in such difficult environments. The industry also requires supportive public policies and initiatives to enhance diagnostics availability during times of political upheavals.

Regions Where The Market In Terms Of Value Is Concentrated

North America dominates the global rapid influenza diagnostic tests market in terms of value. It accounts for over 35% market share due to the high diagnosis rate and rising healthcare spending in the US and Canada. Availability of advanced medical facilities and favorable reimbursement policies support the widespread adoption of rapid influenza tests. Asia Pacific is also a major revenue generator with China, Japan, and India demonstrating high demand. Emerging economies are focusing on strengthening infectious disease control programs. This is increasing the uptake of point-of-care influenza tests across various clinical and non-clinical settings. Europe holds the third position in the high-value market driven by government emphasis on effective healthcare management.

Fastest Growing Region For The Global Rapid Influenza Diagnostic Tests Market

Latin America shows greatest promise as the fastest growing region for the global rapid influenza diagnostic tests market during the forecast period. Factors such as improving public healthcare investments, rising per capita incomes, and growing diseased population drive the uptake of rapid diagnostic technologies. Partnerships between key companies and regional medical institutions are helping expand access to influenza testing across hospitals, diagnostic labs and clinics. On the other hand, Asia Pacific will maintain steady growth on account of rapid economic development, increasing health awareness, heavy R&D investments by market players and favorable reimbursement reforms in several Asian countries. Overall, emerging markets offer huge untapped opportunities for diagnostic suppliers to tap into new customer segments.

What Are The Key Data Covered In This Global Rapid Influenza Diagnostic Tests Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Rapid Influenza Diagnostic Tests's growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Rapid Influenza Diagnostic Tests and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Global Rapid Influenza Diagnostic Tests Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Rapid Influenza Diagnostic Tests vendors

FAQ’s

Q.1 What are the main factors influencing the Global Rapid Influenza Diagnostic Tests?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Global Rapid Influenza Diagnostic Tests companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Global Rapid Influenza Diagnostic Tests’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic: https://teletype.in/@benstiller/o0L1TeyjpGa
Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)